Hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer: Sequencing of chemotherapy and endocrine therapy.
Nicole M. Engel-Nitz
Research Funding - Novartis
Yanni Hao
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Jaqueline Willemann Rogerio
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
James D. Turnbull
Employment or Leadership Position - Novartis
Gabriel Gomez Rey
Research Funding - Novartis
Jane Sullivan
Research Funding - Novartis
Arthur H. Rossof
Employment or Leadership Position - UnitedHealth Group
Stock Ownership - UnitedHealth Group